Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07376070 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After Sternotomy

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 29, 2026 (before its estimated September 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this observational study is to reveal blood biomarkers that will have prognostic significance in terms of the development of deep wound infection following sternotomy. As for the practical significance of the study, blood biomarkers correlated with deep wound infections can be used to prevent the development of wound infections in the postoperative period. Based on this, it is possible to formulate an algorithm for preventive measures.
Trial Details
NCT Number NCT07376070
Lead Sponsor Levan Nebieridze
Conditions
(from sponsor)		 Deep Sternal Infection, Diabete Mellitus, Mediastinitis
Related terms Diabetes Mellitus, Mediastinitis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov